{"id":"https://openalex.org/W7214909646","doi":"https://doi.org/10.3389/fonc.2026.1942370","title":"Real-world management of ovarian cancer in women living with HIV: treatment exposure, immune monitoring, and care barriers in a five-case series","display_name":"Real-world management of ovarian cancer in women living with HIV: treatment exposure, immune monitoring, and care barriers in a five-case series","publication_year":2026,"publication_date":"2026-09-30","ids":{"openalex":"https://openalex.org/W7214909646","doi":"https://doi.org/10.3389/fonc.2026.1942370","pmid":"https://pubmed.ncbi.nlm.nih.gov/42876492","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13661414"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2026.1942370","doi":"https://doi.org/10.3389/fonc.2026.1942370","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1942370","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1942370/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1942370/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100354626","display_name":"Yang Zhang","orcid":"https://orcid.org/0000-0002-0536-7798","observed_orcids":["https://orcid.org/0000-0002-0536-7798"]},"institutions":[{"id":"https://openalex.org/I4210166055","display_name":"Shenzhen Third People\u2019s Hospital","ror":"https://ror.org/04xfsbk97","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210166055"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yang Zhang","raw_affiliation_strings":["Shenzhen Third People\u2019s Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shenzhen Third People\u2019s Hospital","institution_ids":["https://openalex.org/I4210166055"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153666765","display_name":"Fuxiang Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210166055","display_name":"Shenzhen Third People\u2019s Hospital","ror":"https://ror.org/04xfsbk97","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210166055"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Fuxiang Wang","raw_affiliation_strings":["Shenzhen Third People\u2019s Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shenzhen Third People\u2019s Hospital","institution_ids":["https://openalex.org/I4210166055"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5137520150","display_name":"Mingchuan Guo","orcid":"https://orcid.org/0000-0003-4693-7125","observed_orcids":["https://orcid.org/0000-0003-4693-7125"]},"institutions":[{"id":"https://openalex.org/I180726961","display_name":"Shenzhen University","ror":"https://ror.org/01vy4gh70","country_code":"CN","type":"education","lineage":["https://openalex.org/I180726961"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Mingchuan Guo","raw_affiliation_strings":["South China Hospital, Medical School, Shenzhen University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"South China Hospital, Medical School, Shenzhen University","institution_ids":["https://openalex.org/I180726961"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5137746378","display_name":"Jianyu Wan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210166055","display_name":"Shenzhen Third People\u2019s Hospital","ror":"https://ror.org/04xfsbk97","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210166055"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jianyu Wan","raw_affiliation_strings":["Shenzhen Third People\u2019s Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shenzhen Third People\u2019s Hospital","institution_ids":["https://openalex.org/I4210166055"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5147812314","display_name":"Huiyan Liao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210166055","display_name":"Shenzhen Third People\u2019s Hospital","ror":"https://ror.org/04xfsbk97","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210166055"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Huiyan Liao","raw_affiliation_strings":["Shenzhen Third People\u2019s Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shenzhen Third People\u2019s Hospital","institution_ids":["https://openalex.org/I4210166055"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5137763457","display_name":"Ting Mao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210166055","display_name":"Shenzhen Third People\u2019s Hospital","ror":"https://ror.org/04xfsbk97","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210166055"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ting Mao","raw_affiliation_strings":["Shenzhen Third People\u2019s Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shenzhen Third People\u2019s Hospital","institution_ids":["https://openalex.org/I4210166055"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110774075","display_name":"L\u00fc Cui","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210166055","display_name":"Shenzhen Third People\u2019s Hospital","ror":"https://ror.org/04xfsbk97","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210166055"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Lu Cui","raw_affiliation_strings":["Shenzhen Third People\u2019s Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shenzhen Third People\u2019s Hospital","institution_ids":["https://openalex.org/I4210166055"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153622370","display_name":"Wenming Cao","orcid":"https://orcid.org/0009-0004-1601-2564","observed_orcids":["https://orcid.org/0009-0004-1601-2564"]},"institutions":[{"id":"https://openalex.org/I180726961","display_name":"Shenzhen University","ror":"https://ror.org/01vy4gh70","country_code":"CN","type":"education","lineage":["https://openalex.org/I180726961"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Wenming Cao","raw_affiliation_strings":["Shenzhen University General Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shenzhen University General Hospital","institution_ids":["https://openalex.org/I180726961"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5147751039","display_name":"Yutao Gao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210166055","display_name":"Shenzhen Third People\u2019s Hospital","ror":"https://ror.org/04xfsbk97","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210166055"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Yutao Gao","raw_affiliation_strings":["Shenzhen Third People\u2019s Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shenzhen Third People\u2019s Hospital","institution_ids":["https://openalex.org/I4210166055"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5147751039","https://openalex.org/A5153622370"],"corresponding_institution_ids":["https://openalex.org/I180726961","https://openalex.org/I4210166055"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":2.7418,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.93504148,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"16","issue":null,"first_page":"1942370","last_page":"1942370"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9682999849319458,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9682999849319458,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.006599999964237213,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/women-living-with-hiv","display_name":"women living with HIV","score":0.9179999828338623},{"id":"https://openalex.org/keywords/non-aids-defining-cancers","display_name":"non-AIDS-defining cancers","score":0.9539999961853027},{"id":"https://openalex.org/keywords/carboplatin-paclitaxel","display_name":"carboplatin-paclitaxel","score":0.8270000219345093},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.8840000033378601},{"id":"https://openalex.org/keywords/niraparib","display_name":"niraparib","score":0.9950000047683716},{"id":"https://openalex.org/keywords/cd4-count","display_name":"CD4 count","score":0.5609999895095825},{"id":"https://openalex.org/keywords/immune-monitoring","display_name":"immune monitoring","score":0.6140000224113464},{"id":"https://openalex.org/keywords/chemotherapy-toxicity","display_name":"chemotherapy toxicity","score":0.47099998593330383},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.859000027179718},{"id":"https://openalex.org/keywords/barriers-to-care","display_name":"barriers to care","score":0.7329999804496765},{"id":"https://openalex.org/keywords/socioeconomic-barriers","display_name":"socioeconomic barriers","score":0.5429999828338623}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8906000256538391},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.6452000141143799},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5802000164985657},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5598000288009644},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5285000205039978},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5012000203132629},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.48420000076293945},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.45980000495910645},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.41819998621940613},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.37450000643730164},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3702000081539154},{"id":"https://openalex.org/C2780252810","wikidata":"https://www.wikidata.org/wiki/Q1455316","display_name":"Immunosuppression","level":2,"score":0.36550000309944153},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.359499990940094},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3515999913215637},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.34130001068115234},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.3407000005245209},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.3393000066280365},{"id":"https://openalex.org/C147077947","wikidata":"https://www.wikidata.org/wiki/Q1515895","display_name":"Socioeconomic status","level":3,"score":0.3244999945163727},{"id":"https://openalex.org/C2779357621","wikidata":"https://www.wikidata.org/wiki/Q655495","display_name":"Tanzania","level":2,"score":0.2992999851703644},{"id":"https://openalex.org/C2775934546","wikidata":"https://www.wikidata.org/wiki/Q179991","display_name":"Biopsy","level":2,"score":0.2969000041484833},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.28940001130104065},{"id":"https://openalex.org/C205545832","wikidata":"https://www.wikidata.org/wiki/Q17156455","display_name":"Young adult","level":2,"score":0.2685000002384186},{"id":"https://openalex.org/C2780435969","wikidata":"https://www.wikidata.org/wiki/Q5625186","display_name":"Gynecologic oncology","level":2,"score":0.2630000114440918},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.25209999084472656}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fonc.2026.1942370","doi":"https://doi.org/10.3389/fonc.2026.1942370","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1942370","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1942370/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13661414","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13661414/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13661414/pdf/fonc-16-1942370.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Oncol","raw_type":"Text"},{"id":"pmid:42876492","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42876492","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in oncology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:bbac26e85c4c4aafa8f37fa294dd9a23","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/bbac26e85c4c4aafa8f37fa294dd9a23","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Oncology, Vol 16 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2026.1942370","doi":"https://doi.org/10.3389/fonc.2026.1942370","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1942370","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1942370/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320329860","display_name":"National Science and Technology Major Project","ror":null}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7214909646.pdf","grobid_xml":"https://content.openalex.org/works/W7214909646.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W1993654534","https://openalex.org/W1997884885","https://openalex.org/W2085656447","https://openalex.org/W3012095810","https://openalex.org/W3137904213","https://openalex.org/W3164186600","https://openalex.org/W3180599892","https://openalex.org/W4220922820","https://openalex.org/W4360868538","https://openalex.org/W4382343798","https://openalex.org/W4385318679","https://openalex.org/W4386945070","https://openalex.org/W4390113375","https://openalex.org/W4405045603","https://openalex.org/W4405401354","https://openalex.org/W4408162885","https://openalex.org/W4409050924","https://openalex.org/W4409410037","https://openalex.org/W4410202396","https://openalex.org/W4410300554","https://openalex.org/W4410607334","https://openalex.org/W4410943752","https://openalex.org/W4411554809","https://openalex.org/W4411687766","https://openalex.org/W4411712567","https://openalex.org/W4413139928","https://openalex.org/W4413245272","https://openalex.org/W4413420027","https://openalex.org/W4414651538","https://openalex.org/W4415837694","https://openalex.org/W4416115579","https://openalex.org/W4417490200"],"related_works":["https://openalex.org/W7163318149","https://openalex.org/W2085656447","https://openalex.org/W2077767312","https://openalex.org/W1997884885","https://openalex.org/W4390971900","https://openalex.org/W3210329618","https://openalex.org/W4394762777","https://openalex.org/W4412042215","https://openalex.org/W3214178872","https://openalex.org/W3093653560"],"abstract_inverted_index":{"Background":[0],"With":[1],"improved":[2],"survival":[3],"among":[4],"people":[5],"living":[6,17],"with":[7,18,61,147,179,199,222],"HIV":[8,19,88,104,131,195],"(PLWH),":[9],"non-AIDS-defining":[10],"cancers":[11],"have":[12],"become":[13],"increasingly":[14],"prominent.":[15],"Women":[16],"(WLWH)":[20],"remain":[21,253],"underrepresented":[22,257],"in":[23],"ovarian":[24,62],"cancer":[25,63],"trials,":[26],"leaving":[27],"limited":[28],"evidence":[29],"on":[30,86,111,154],"the":[31,112,231],"tolerability":[32],"of":[33],"standard":[34],"therapies,":[35],"including":[36],"chemotherapy,":[37],"anti-VEGF":[38],"agents,":[39],"and":[40,74,103,108,159,213,248],"PARP":[41],"inhibitors.":[42],"These":[43],"patients":[44,163],"also":[45],"face":[46],"unique":[47],"care":[48,247],"barriers":[49,252],"beyond":[50],"biological":[51],"uncertainties.":[52],"Methods":[53],"This":[54,206],"retrospective":[55],"review":[56],"included":[57],"five":[58],"WLWH":[59,221],"diagnosed":[60],"(June":[64],"2022\u2013March":[65],"2024).":[66],"Three":[67],"received":[68],"anticancer":[69],"treatment;":[70],"one":[71,79,140,170],"refused":[72],"chemotherapy":[73],"was":[75,119],"lost":[76],"to":[77,176,187,219,241,250],"follow-up;":[78],"had":[80,123,192],"biopsy":[81],"only.":[82],"We":[83],"collected":[84],"data":[85],"demographics,":[87],"history,":[89],"tumor":[90],"characteristics,":[91],"treatment":[92],"exposure,":[93],"adverse":[94],"events":[95,135],"(CTCAE":[96],"v5.0),":[97],"CD4":[98,166,227],"+":[99,101,167,228],"/CD8":[100],"counts,":[102],"RNA,":[105],"focusing":[106],"safety":[107],"immune":[109,235],"analyses":[110],"three":[113],"treated":[114],"patients.":[115],"Results":[116],"Median":[117],"age":[118],"51":[120],"years;":[121],"four":[122],"stage":[124],"III\u2013IV":[125],"disease.":[126],"No":[127],"treatment-related":[128],"deaths,":[129],"persistent":[130],"rebound,":[132],"or":[133],"AIDS-defining":[134],"occurred.":[136],"During":[137],"first-line":[138],"paclitaxel/carboplatin,":[139],"patient":[141,191],"developed":[142,151],"grade":[143],"3":[144],"neutropenia":[145],"managed":[146],"G-CSF,":[148],"but":[149],"later":[150],"significant":[152],"thrombocytopenia":[153],"niraparib":[155],"requiring":[156],"dose":[157],"reduction":[158],"hospitalization.":[160],"Among":[161],"two":[162],"receiving":[164],"bevacizumab,":[165],"patterns":[168],"diverged:":[169],"showed":[171],"a":[172],"transient":[173],"decline":[174],"(387":[175],"259":[177],"cells/\u03bcL)":[178],"concurrent":[180,198],"nedaplatin;":[181],"another":[182],"maintained":[183],"stable":[184],"counts":[185],"(150":[186],"200":[188],"cells/\u03bcL).":[189],"One":[190],"transient,":[193],"self-limited":[194],"RNA":[196],"elevation":[197],"disease":[200],"progression,":[201],"which":[202],"resolved":[203],"spontaneously.":[204],"Conclusion":[205],"series":[207],"provides":[208],"real-world":[209],"observations":[210],"that":[211],"platinum-based":[212],"targeted":[214],"therapies":[215],"may":[216],"be":[217],"delivered":[218],"selected":[220],"close":[223],"monitoring.":[224],"The":[225],"heterogeneous":[226],"responses":[229],"highlight":[230],"need":[232],"for":[233,255],"individualized":[234],"surveillance":[236],"rather":[237],"than":[238],"attributing":[239],"changes":[240],"any":[242],"single":[243],"agent.":[244],"Integrated":[245],"oncologic-HIV":[246],"attention":[249],"socioeconomic":[251],"critical":[254],"this":[256],"population.":[258]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2026-10-01T00:00:00"}